Profile data is unavailable for this security.
About the company
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
- Revenue in USD (TTM)187.32m
- Net income in USD8.05m
- Incorporated2020
- Employees194.00
- LocationBiote Corp1875 W. Walnut Hill Ln #100, Floor 5IRVING 75038United StatesUSA
- Phone+1 (972) 486-9346
- Fax+1 (916) 443-1908
- Websitehttps://haymakeracquisition.com/
Mergers & acquisitions
Acquired company | BTMD:NMQ since announced | Transaction value |
---|---|---|
FH Investments Inc | 60.30% | 9.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Goodheart-Willcox Company Inc | -100.00bn | -100.00bn | 239.85m | 56.00 | -- | 6.62 | -- | -- | -- | -- | -- | 61.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 21.66 | -- | 78.03 | -- | -- | -- |
Chegg Inc | 703.04m | 14.57m | 283.14m | 1.90k | 35.58 | 0.292 | 2.05 | 0.4027 | 0.0779 | 0.0779 | 5.63 | 9.49 | 0.3434 | -- | 30.08 | 369,439.80 | 0.7119 | 2.58 | 0.845 | 2.77 | 68.61 | 70.64 | 2.07 | 8.07 | -- | -- | 0.3839 | 0.00 | -6.60 | 17.41 | -93.18 | -- | 21.61 | -- |
Value Line, Inc. | 38.20m | 18.27m | 441.56m | 138.00 | 24.19 | 4.95 | 22.46 | 11.56 | 1.94 | 1.94 | 4.05 | 9.47 | 0.2896 | -- | 24.80 | 276,826.10 | 13.84 | 16.44 | 16.65 | 21.31 | 85.67 | 86.90 | 47.81 | 46.72 | -- | -- | 0.00 | 45.41 | -2.05 | 2.05 | -24.15 | 4.16 | -19.26 | 6.79 |
biote Corp | 187.32m | 8.05m | 458.45m | 194.00 | 45.80 | -- | 28.57 | 2.45 | 0.1614 | 0.1614 | 6.22 | -1.04 | 1.34 | 4.02 | 23.91 | 965,572.20 | 9.18 | -- | 9.15 | -- | 69.38 | -- | 6.84 | -- | 3.97 | 6.13 | 1.67 | -- | 12.37 | -- | 442.21 | -- | -- | -- |
Daily Journal Corporation | 71.82m | 22.22m | 548.61m | 350.00 | 24.69 | 2.40 | 24.39 | 7.64 | 16.14 | 16.14 | 52.15 | 165.94 | 0.2067 | 96.37 | 4.93 | 205,194.30 | 6.40 | 2.53 | 7.09 | 2.83 | 89.13 | 90.83 | 30.94 | 13.92 | 8.97 | -- | 0.1182 | 0.00 | 25.37 | 10.71 | 128.37 | -- | -16.51 | -- |
Gannett Co Inc | 2.63bn | -122.90m | 686.10m | 12.80k | -- | 2.94 | 20.00 | 0.2608 | -0.872 | -0.872 | 18.73 | 1.58 | 1.19 | 50.81 | 10.51 | 205,499.50 | -5.57 | -7.31 | -7.40 | -9.39 | 36.73 | 39.19 | -4.67 | -7.35 | 0.7489 | 0.6546 | 0.8161 | -- | -9.57 | 11.78 | 64.37 | -- | 26.78 | -- |
Scholastic Corp | 1.64bn | 51.90m | 996.91m | 4.98k | 24.03 | 0.9993 | 8.48 | 0.6067 | 1.45 | 1.45 | 52.33 | 34.87 | 0.9147 | 2.26 | 6.38 | 329,939.80 | 2.89 | 1.32 | 4.43 | 1.88 | 55.38 | 51.86 | 3.16 | 1.65 | 0.7333 | -- | 0.0306 | 86.61 | 3.72 | 0.9117 | 7.07 | 161.93 | -10.82 | 4.56 |
Cengage Learning Holdings II Inc | 1.50bn | -80.90m | 1.26bn | 4.40k | -- | -- | 9.75 | 0.8353 | -1.30 | -1.30 | 24.05 | 1.84 | 0.5728 | 10.49 | 7.45 | 341,522.70 | -3.08 | -8.41 | -4.22 | -10.83 | 52.83 | 50.59 | -5.38 | -17.26 | 0.7547 | 0.8423 | 0.9336 | -- | 5.56 | 0.9882 | -101.24 | -- | -4.80 | -- |
Holder | Shares | % Held |
---|---|---|
325 Capital LLCas of 31 Mar 2024 | 3.77m | 12.42% |
Roystone Capital Management LPas of 31 Dec 2023 | 3.07m | 10.13% |
Bandera Partners LLCas of 31 Mar 2024 | 2.01m | 6.61% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.38m | 4.55% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 883.53k | 2.91% |
Boston Partners Global Investors, Inc.as of 31 Mar 2024 | 713.74k | 2.35% |
Wasatch Advisors LPas of 31 Mar 2024 | 669.86k | 2.21% |
SW Investment Management LLCas of 31 Mar 2024 | 500.00k | 1.65% |
Geode Capital Management LLCas of 31 Mar 2024 | 480.40k | 1.58% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 274.18k | 0.90% |